Predictive Clinical and Biological Parameters in Gynecological Cancer

N/AActive Not RecruitingNCT01977274

Institut Paoli-Calmettes300 enrolled

Overview

Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation

Study Type

INTERVENTIONAL

Allocation

Purpose

BASIC_SCIENCE

Masking

NONE

Enrollment

300

Conditions

Ovarian Cancer Endometrium Cancer Cervix Cancer

Interventions

gynecological cancerOTHER

blood and tumor samples

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * gynecological cancer suspicion * age \> 18 * signed informed consent Exclusion Criteria: \- emergency Exclusion criteria after histological exam Any diagnosis that is not a gynecological cancer (ovarian, cervix, endometrium).

Locations (1)

Institut Paoli Calmettes

Marseille, France

Outcomes

Primary Outcomes

molecular alteration in gynecological cancer

gene expression level

Time frame: average of 4 weeks after diagnosis

Secondary Outcomes

relation between molecular alteration and clinical and histological characteristics

hazard ratio between molecular alteration and clinico-histological characteristics

Time frame: up to 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.